ENGLISH

CARMELINA subgroup analysis supports long-term cardiovascular and renal safety of linagliptin in older people with type 2 diabetes

• Linagliptin did not increase the risk of adverse cardiovascular events, hospitalization for heart failure or adverse kidney events compared with placebo in older people with type 2 diabetes in a prespecified subgroup analysis of the CARMELINA cardiovascular outcome trial1 • In addition, linagliptin did not increase the risk of …

أكمل القراءة »

Ingram Micro Continues to Strengthen Latin American Operations to Deliver Even More Sustainable Value for Customers and Partners

Ingram Micro Inc. today announced it is continuing its commitment to be the partner of choice in Latin American (LATAM) with continued investment across the region aimed at creating and delivering even more sustainable business value for its channel partners and customers. “We continue to invest into our LATAM organization …

أكمل القراءة »

UAE unveils new investment and development initiative to help build a connected and ‘turbocharged’ new Africa driven by youth

  ‘Consortium for Africa’, will combine ambition and resources to support progress USD 500m investment to focus on youth and digitisation African Union hears how Consortium demonstrates UAE’s relentless commitment to the continent   The UAE’S Consortium for Africa, a new initiative with a committed investment of USD 500 million …

أكمل القراءة »

Aptorum Group Announces Further Positive Data For Its ALS-4 Small Molecule Anti-virulence

Aptorum Group

Aptorum Group Limited (NASDAQ: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces further positive data from its current investigational new drug (IND) – enabling studies for ALS-4, a small drug molecule candidate indicated for the treatment of infections …

أكمل القراءة »